ACRS icon

Aclaris Therapeutics

97 hedge funds and large institutions have $58.1M invested in Aclaris Therapeutics in 2024 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 20 increasing their positions, 38 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

more first-time investments, than exits

New positions opened: | Existing positions closed:

2.59% less ownership

Funds ownership: 76.75%74.15% (-2.6%)

14% less capital invested

Capital invested by funds: $67.8M → $58.1M (-$9.68M)

47% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 38

Holders
97
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$51K
Puts
$4K
Net Calls
Net Calls Change

Top Buyers

1 +$3.95M
2 +$2.12M
3 +$2.08M
4
AC
Aldebaran Capital
Indiana
+$944K
5
Goldman Sachs
Goldman Sachs
New York
+$848K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$14.3M
2
$5.16M
3
$3.67M
4
$3.65M
5
$3.03M
6
$2.24M
7
$2.12M
8
$2.1M
9
$2.08M
10
$1.58M
11
$1.22M
12
$1.1M
13
$1.03M
14
$1.02M
15
$1.01M
16
$1.01M
17
$963K
18
$944K
19
$852K
20
$766K
21
$758K
22
$627K
23
$573K
24
$511K
25
$478K